Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HydroVax-005 by Najit Technologies for Chikungunya Fever: Likelihood of Approval
HydroVax-005 is under clinical development by Najit Technologies and currently in Phase I for Chikungunya Fever. According to GlobalData, Phase...